Asia Pacific Immunodiagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Product (Enzyme-Linked Immunosorbent Assays (ELISA), Chemiluminescence Immunoassays (CLIA), Radioimmunoassays (RIA), and Others), By Clinical Indication (Infectious Diseases, Hepatitis+HIV, Endocrinology, Gastrointestinal, Metabolics, and Others), and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others)

No. of Pages: 225    |    Report Code: BMIRE00027857    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Immunodiagnostics Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Immunodiagnostics Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia Pacific Immunodiagnostics Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing Prevalence of Infectious Diseases
  • 5.1.2 Increasing Use of Point-of-Care Immunodiagnostics
5.2 Market Opportunities
  • 5.2.1 Rising Focus On R&D Investment and Expansion by Key Players
5.3 Future Trends
  • 5.3.1 Technological Advancements in The Field of Immunodiagnostics
5.4 Impact of Drivers and Restraints

6. Asia Pacific Immunodiagnostics Market Regional Analysis

6.1 Asia Pacific Immunodiagnostics Market Overview
6.2 Asia Pacific Immunodiagnostics Market Revenue 2021-2030 (US$ Million)
6.3 Asia Pacific Immunodiagnostics Market Forecast Analysis

7. Asia Pacific Immunodiagnostics Market Analysis – by Product

7.1 Enzyme-Linked Immunosorbent Assays
  • 7.1.1 Overview
  • 7.1.2 Enzyme-Linked Immunosorbent Assays: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Chemiluminescence Immunoassays
  • 7.2.1 Overview
  • 7.2.2 Chemiluminescence Immunoassays: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Radioimmunoassays
  • 7.3.1 Overview
  • 7.3.2 Radioimmunoassays: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Immunodiagnostics Market Analysis – by Clinical Indication

8.1 Infectious Diseases
  • 8.1.1 Overview
  • 8.1.2 Infectious Diseases: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Hepatitis+HIV
  • 8.2.1 Overview
  • 8.2.2 Hepatitis+HIV: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Endocrinology
  • 8.3.1 Overview
  • 8.3.2 Endocrinology: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Gastrointestinal
  • 8.4.1 Overview
  • 8.4.2 Gastrointestinal: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Metabolics
  • 8.5.1 Overview
  • 8.5.2 Metabolics: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Immunodiagnostics Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Metabolics: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Clinics
  • 9.2.1 Overview
  • 9.2.2 Metabolics: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Diagnostic Laboratories
  • 9.3.1 Overview
  • 9.3.2 Metabolics: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Academic & Research Institutes
  • 9.4.1 Overview
  • 9.4.2 Metabolics: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Immunodiagnostics Market – Asia-Pacific Analysis

10.1 Asia-Pacific
  • 10.1.1 Asia Pacific Immunodiagnostics Market Breakdown, by Key Country, 2024 and 2030 (%)
  • 10.1.1.1 Asia Pacific Immunodiagnostics Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 China: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 China: Asia Pacific Immunodiagnostics Market Breakdown, by Product
    • 10.1.1.1.2 China: Asia Pacific Immunodiagnostics Market Breakdown, by Clinical Indication
    • 10.1.1.1.3 China: Asia Pacific Immunodiagnostics Market Breakdown, by End User
  • 10.1.1.2 India: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 India: Asia Pacific Immunodiagnostics Market Breakdown, by Product
    • 10.1.1.2.2 India: Asia Pacific Immunodiagnostics Market Breakdown, by Clinical Indication
    • 10.1.1.2.3 India: Asia Pacific Immunodiagnostics Market Breakdown, by End User
  • 10.1.1.3 Japan: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 Japan: Asia Pacific Immunodiagnostics Market Breakdown, by Product
    • 10.1.1.3.2 Japan: Asia Pacific Immunodiagnostics Market Breakdown, by Clinical Indication
    • 10.1.1.3.3 Japan: Asia Pacific Immunodiagnostics Market Breakdown, by End User
  • 10.1.1.4 Australia: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.4.1 Australia: Asia Pacific Immunodiagnostics Market Breakdown, by Product
    • 10.1.1.4.2 Australia: Asia Pacific Immunodiagnostics Market Breakdown, by Clinical Indication
    • 10.1.1.4.3 Australia: Asia Pacific Immunodiagnostics Market Breakdown, by End User
  • 10.1.1.5 Rest of Asia-Pacific : Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Immunodiagnostics Market Breakdown, by Product
    • 10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Immunodiagnostics Market Breakdown, by Clinical Indication
    • 10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Immunodiagnostics Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Asia Pacific Immunodiagnostics Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott Laboratories
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 bioMerieux SA
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Danaher Corp
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 DiaSorin SpA
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 PerkinElmer Inc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Siemens Healthcare GmbH
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Svar Life Science AB
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Thermo Fisher Scientific Inc
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - A Market

  1. Abbott Laboratories                
  2. bioMerieux SA                             
  3. Danaher Corp                                 
  4. DiaSorin SpA                                  
  5. F. Hoffmann-La Roche Ltd           
  6. PerkinElmer Inc                               
  7. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. 
  8. Siemens Healthcare GmbH                  
  9. Svar Life Science AB                       
  10. Thermo Fisher Scientific Inc         
asia-pacific-immunodiagnostics-market